Stryker named Spencer Stiles CEO. Stryker stock costs EUR 249.25

Published on 10/09/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 6.59 billion in second-quarter 2026, up 9.4 percent. Stryker stock costs EUR 249.25 versus EUR 246.85 on October 9, 2026.

Key points in brief

Stryker named Spencer Stiles as CEO effective January 1, 2027, with Kevin Lobo moving to executive chair.
Second-quarter 2026 revenue reached USD 6.59 billion, up 9.4 percent year over year.
Stryker stock was trading at EUR 249.25 at Lang & Schwarz on October 9, 2026, plus 0.97 percent versus EUR 246.85.
The company is scheduled to report third-quarter 2026 results on October 29, 2026.

Schwarzweiß-Dokumentarfoto von Klinikpersonal mit sterilem Instrumentenwagen im Flur — Schwarzweiß-Reportagefoto zeigt Klinikpersonal mit Instrumentenwagen, passend zu Stryker Corp. US8636671013 im Medizintechnik-Sektor, Illustration mit AI erstellt.

Stryker Corp. (ISIN US8636671013) was trading at EUR 249.25 at Lang & Schwarz on October 9, 2026 at 3:37 p.m. CEST, plus 0.97 percent versus the prior close of EUR 246.85. According to FinanzNachrichten on October 6, 2026, Stryker named President and Chief Operating Officer Spencer Stiles as its next chief executive officer, effective January 1, 2027, while Kevin Lobo moves to executive chair.

Three events shape the timeline

On July 30, 2026, Stryker reported second-quarter revenue of USD 6.59 billion, up 9.4 percent year over year, and adjusted earnings per share of USD 3.69, above the USD 3.49 consensus estimate, according to MarketBeat.

On September 8, 2026, the company said a manufacturing problem in its Peripheral Vascular unit was continuing into the third quarter and could extend into the fourth quarter, as reported by Trivano. On October 6, 2026, the leadership succession announcement put the continuity of execution back at the center of the company story, according to FinanzNachrichten.

What does the transition mean for execution

The succession preserves an internal operating handoff rather than introducing an external chief executive. Stryker said Lobo completed more than 60 acquisitions during his tenure, while annual net sales grew from USD 8.7 billion in 2012 to more than USD 26 billion in 2026, according to FinanzNachrichten. The measurable test for Stiles is whether that scale can be maintained while Peripheral Vascular supply constraints are resolved.

Results and dividend dates

Sync2Cal lists October 29, 2026 as the next reporting date for third-quarter 2026 results, with an estimated revenue of USD 6.70 billion. MarketBeat lists October 30, 2026 as the payment date for the USD 0.88 quarterly dividend.

EUR 249.25 versus the prior close

On the NYSE, Stryker was last at USD 280.25 at 9:44 a.m. ET on October 9, 2026. Its USD 267.00 to USD 392.55 52-week range places that primary-exchange price 28.61 percent below the high, while its market capitalization was USD 107.4 billion on the same date.

At Lang & Schwarz, Stryker was trading at EUR 249.25 on October 9, 2026 at 3:37 p.m. CEST, plus 0.97 percent versus the EUR 246.85 prior close of October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Stryker stock.